Cooper Companies (COO) Cash from Operations (2009 - 2026)
Cooper Companies (COO) posted Cash from Operations of $182.8 million for Q2 2026, down 29.93% on a QoQ basis from $260.9 million in Q1 2026, and up 90.02% year-over-year from $96.2 million in Q2 2025.
Analysis
Cooper Companies (COO) Cash from Operations (2009 - 2026) Analysis & Trends
Cooper Companies has reported Cash from Operations for 18 years, with the latest figure at $182.8 million in Q2 2026.
- On a quarterly basis, Cash from Operations rose 90.02% year-over-year to $182.8 million in Q2 2026; TTM through Apr 2026 was $953.0 million, a 25.0% increase from a year earlier, with the FY2025 full-year figure at $796.1 million, up 12.24% from the prior year.
- Cash from Operations was $182.8 million for Q2 2026 at Cooper Companies, down from $260.9 million in the prior quarter.
- The five-year high for Cash from Operations was $268.1 million in Q4 2024, with the low at $96.2 million in Q2 2025.
- Average Cash from Operations over 5 years is $180.5 million, with a median of $170.4 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2026: Cash from Operations sank 46.0% in 2023, then surged 90.02% in 2026.
- Over 5 years, Cash from Operations stood at $130.7 million in 2022, then surged by 33.28% to $174.2 million in 2023, then soared by 53.9% to $268.1 million in 2024, then fell by 7.53% to $247.9 million in 2025, then decreased by 26.26% to $182.8 million in 2026.
- The last three Cash from Operations figures came in at $182.8 million (Q2 2026), $260.9 million (Q1 2026), and $247.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 1.06 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 1.79 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 1.26 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 651.90 Mn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | 510.00 Mn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 269.20 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Cooper Companies | 10.51 Bn | 10.37 Bn | 735.40 Mn | 182.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 182.80 Mn |
| Jan 31, 2026 | 260.90 Mn |
| Oct 31, 2025 | 247.90 Mn |
| Jul 31, 2025 | 261.40 Mn |
| Apr 30, 2025 | 96.20 Mn |
| Jan 31, 2025 | 190.60 Mn |
| Oct 31, 2024 | 268.10 Mn |
| Jul 31, 2024 | 207.50 Mn |
| Apr 30, 2024 | 111.00 Mn |
| Jan 31, 2024 | 122.70 Mn |
| Oct 31, 2023 | 174.20 Mn |
| Jul 31, 2023 | 142.50 Mn |
| Apr 30, 2023 | 124.20 Mn |
| Jan 31, 2023 | 166.60 Mn |
| Oct 31, 2022 | 130.70 Mn |
| Jul 31, 2022 | 263.90 Mn |
| Apr 30, 2022 | 131.80 Mn |
| Jan 31, 2022 | 166.00 Mn |
| Oct 31, 2021 | 174.50 Mn |
| Jul 31, 2021 | 223.80 Mn |